SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-008102
Filing Date
2021-02-10
Accepted
2021-02-10 17:13:48
Documents
8
Period of Report
2021-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea134993-8k_optimizerx.htm 8-K 21694
2 UNDERWRITING AGREEMENT ea134993ex1-1_optimizerx.htm EX-1.1 258713
3 OPINION OF THE DONEY LAW FIRM ea134993ex5-1_optimizerx.htm EX-5.1 7174
4 OPTIMIZERX ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK ea134993ex99-1_optimizerx.htm EX-99.1 9807
5 OPTIMIZERX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK ea134993ex99-2_optimizerx.htm EX-99.2 9950
6 GRAPHIC ex99-1_001.jpg GRAPHIC 15958
7 GRAPHIC ex99-2_001.jpg GRAPHIC 15958
8 GRAPHIC image_001.gif GRAPHIC 9486
  Complete submission text file 0001213900-21-008102.txt   365835
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 21615039
SIC: 7389 Services-Business Services, NEC